Abstract

AbstractWhile growing neurites are relatively plastic during development, their plasticity levels drop rapidly as neurons mature and become integrated into neuronal networks. As a consequence, the central nervous system ability to reorganize itself in response to injury or disease is insufficient. One of the main limitations for the design of therapeutic strategies to enhance neurite sprouting following neurological diseases is our poor understanding of the mechanisms underlying neurite structural plasticity. To overcome this limitation, we have implemented a strategy to identify, characterize and validate the most therapeutically relevant drug targets to modulate neuronal plasticity. This strategy is based on the hypothesis that the molecular regulation of the neurite shaft (controlling its ability to sprout) shares similarities with other cell systems. In an initial selection step (1), candidate targets are identified from the literature based on predetermined criteria (e.g. involvement in cell migration and growth cone collapse). (2) Compounds acting on those targets are tested in a neuronal cell-based assay for their effects on neurite sprouting as well as for early detection of undesired effects. (3) The selected targets are further analyzed during a verification step where their subcellular expression and activity is assessed. The regulation of the activity of the potential targets by branching factors is also determined at this point. (4) Once the biological relevance has been established, the signalling pathway in which the potential targets operates within neurons is mapped using activity reporters to uncover additional potential targets. This candidate approach, combined with the use of primary neurons, is designed to increase the probability of identifying suitable targets at the same time that it minimizes costs and time to validation. By using this strategy, we have been able to identify a set of proteins controlling neuronal sprouting together with an unsuspected mechanism of regulation of structural plasticity in neurons.

Highlights

  • Candidate targets for neuronal plasticityGrowing neurons are relatively plastic during development, which allows their neurites to sprout and generate new connections.Plasticity levels drop rapidly as neurons mature and become integrated into neuronal networks

  • The central nervous system ability to reorganize itself in response to injury or disease is insufficient

  • One of the main limitations for the design of therapeutic strategies to enhance neurite sprouting following neurological diseases is our poor understanding of the mechanisms underlying neurite structural plasticity

Read more

Summary

Candidate targets for neuronal plasticity

Growing neurons are relatively plastic during development, which allows their neurites to sprout and generate new connections. Plasticity levels drop rapidly as neurons mature and become integrated into neuronal networks. The central nervous system ability to reorganize itself in response to injury or disease is insufficient. One of the main limitations for the design of therapeutic strategies to enhance neurite sprouting following neurological diseases is our poor understanding of the mechanisms underlying neurite structural plasticity. Goal: Identify therapeutically relevant drug targets to stimulate neuronal plasticity

Aberrant morphology
MT regulator Actin regulator
Dendrites Somas
Calcium Erk cAMP
Sufficiency to promote sprouting
CONCLUSIONS
Necessity for sprouting in response to branching factors
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call